ALFA FinderNSE filing, NSE: TATAELXSI. Summary written from the filing by ALFA Finder's alert engine.
Tata Elxsi Ltd: key numbers
- Share price
- ₹3,876.00
- Market cap
- ₹24,150 Cr
- Revenue (annual)
- ₹3,757 Cr
- Net profit (annual)
- ₹628.4 Cr
- P/E (TTM)
- 36.0×Sector 23.6×
- Promoter holding
- 43.89%-0.01% QoQ
- FII holding
- 8.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tata Elxsi Ltd
All →Tata Elxsi Other Announcement
Tata Elxsi filed its quarterly shareholding pattern as of 30 June 2025. This routine periodic disclosure reports holdings only, with no transaction or corporate event.
Tata Elxsi Other Announcement
Tata Elxsi Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Tata Elxsi Earnings Call Transcript: Key Takeaways
Tata Elxsi reported steady constant currency revenue growth and margin expansion despite wage hikes.
Tata Elxsi Management Change
Tata Elxsi Limited has appointed Deloitte Haskins & Sells Chartered Accountants LLP as the new statutory auditor for a 60-month term effective from April 1, 2027.
Tata Elxsi Employee Stock Options
Tata Elxsi Limited allotted 686 equity shares to employees upon the exercise of performance stock options. This allotment increases the company's paid-up equity share capital.
Tata Elxsi Investor Presentation: Key Takeaways
Tata Elxsi reported Q2 FY27 revenue of Rs. 1,055.7 Cr, up 3.4% QoQ. Strategy focuses on broad-based growth across Transportation, Media, and Healthcare using GenAI.
Other product launch announcements
All →Bharat Forge Product Launch
Bharat Forge's defence subsidiary KSSL unveiled the 120mm Rapid Attack Mortar System for Indian Armed Forces and international customers. No order value or contract was announced.
Lupin Product Launch
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
LTM Product Launch
LTM publishes AI-QEM, its Quantum Error Mitigation tool, in IBM's Quantum Functions Catalog, becoming the first global systems integrator to do so.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.